PARADISE launches new personalised prediction tool for individuals with Vasculitis

19 April 2024

The PARADISE project has recently launched a basic informational video tool tailored for individuals living with Vasculitis, as well as those newly encountering these conditions, including healthcare professionals, researchers, academics, the general public, and those involved in planning services.

The videos, ’10 things to know about Vasculitis‘, are now available in 9 languages: English, Croatian, Dutch, French, German, Spanish, Swedish, Italian and Greek. (Access on Youtube here.)

The video was initiated, designed and delivered by the Patient Advisory Group in the PARADISE project, this group are ensuring that the patient perspective is at the heart of this research.

PARADISE, PersonAlisation of RelApse risk in autoimmune DISEase, is a collaborative project between the ADAPT Centre and Trinity Translational Medicine Institute, funded by ERAPerMed, coordinated by Mark Little (ADAPT Principal Investigator at Trinity College Dublin). The project’s primary objective is to develop a personalised prediction tool aimed at assisting in the management of recurrent autoimmune diseases.

For more information, please visit the PARADISE project website here.